The Supreme Court’s Cannabis Ruling Could Bring More Customers Through Dispensary Doors

For many Americans, the U.S. Supreme Court’s decision in United States v. Hemani made headlines because it expanded Second Amendment protections for cannabis users.

For cannabis operators, however, the decision may carry a different significance.

According to Dan Russell, partner at Jones Walker LLP and former general counsel of Surterra Florida, the ruling represents another step in the federal government’s gradual shift toward treating cannabis less like a prohibited drug and more like a regulated consumer product.

While the case itself centers on firearm rights, Russell believes its broader implications could influence regulators, employers, investors, and even patient adoption over time.

More Than A Gun Rights Case

Many readers saw headlines suggesting the Supreme Court had restored firearm rights to cannabis users, but Russell cautions that the case should first be understood as a constitutional decision.

“While the ruling has an impact in the world of cannabis, this is primarily a Second Amendment ruling,” he said.

The Court concluded that automatically prohibiting every cannabis user from possessing firearms is not consistent with the nation’s historical tradition of firearm regulation under the circumstances presented in the case.

For Russell, that establishes an important legal precedent—even if it does not directly rewrite cannabis law.

Could More Customers Walk Into Dispensaries?

Although the ruling does not change how dispensaries operate, Russell believes it could remove one barrier that kept certain consumers away from legal cannabis.

“This decision may change some things for cannabis businesses,” he said. “Any portion of the population who may have refused to use cannabis solely due to its use preventing them from owning a firearm might now feel more empowered to use cannabis.”

For operators, particularly in medical markets with large hunting, sporting, or rural populations, that could translate into incremental patient growth.

Russell believes the industry may be underestimating how closely firearm owners were following the case.

“I am commonly asked, ‘What happens to your gun rights when you become a medical marijuana patient?'” he said. “The industry might not appreciate how many gun owners were following Hemani, such that there could be a significant influx of new customers at dispensaries.”

A Signal Of Broader Federal Change?

The decision also arrives during a period of rapid change in federal cannabis policy.

Medical cannabis has already been moved to Schedule III under Acting Attorney General Todd Blanche’s April order, while the DEA continues hearings on whether broader cannabis rescheduling should follow.

Could Hemani influence how regulators and courts approach other conflicts between federal law and state-legal cannabis?

Russell believes it could.

“Having received a ruling from a conservative SCOTUS that cannabis users are no longer ‘too dangerous’ to own a firearm could lead otherwise super-conservative legislative and executive branch leaders to lean in a more moderate direction on cannabis, especially in medical jurisdictions.”

What Does It Mean For Schedule III?

Many cannabis executives are now preparing for a post-Schedule III environment.

Asked whether the Court’s reasoning offers any clues about how judges may approach cannabis restrictions moving forward, Russell drew a comparison between cannabis and alcohol.

“Cannabis is effectively no different than alcohol in America as of June 2026,” he said.

“Both are widely available in most states to adults aged 21 and over at their local retail store.”

That does not mean governments lose their ability to regulate cannabis.

Instead, Russell expects restrictions to increasingly resemble those applied to alcohol.

“This leads to time/place/manner restrictions for both products such that the government cannot allow people to use them while driving, operating heavy equipment, carrying a firearm, etc., but the idea that having a casual usage of marijuana prevents you from ever doing any of the above no longer exists.”

Could Other Business Barriers Begin To Fall?

One question operators continue asking is whether legal normalization eventually spills into other areas of business.

Could banking, insurance, lending, employment, or workplace policies change next?

Russell believes employment could move first.

“Maybe, and the first impact might be on employment,” he said.

“Many companies eliminated THC from their standard drug screenings… and for obvious reasons.”

With hemp-derived THC products widely available and legal cannabis becoming increasingly common across the country, he says employers are becoming less concerned with off-duty consumption.

“Hemp-derived THC products being sold everywhere, plus the near ubiquity of other THC products in most states, is making most employers indifferent to off-the-clock consumption.”

What Should Investors Take Away?

For investors looking for signals of a more predictable federal regulatory environment, Russell advises against viewing Hemani in isolation.

“This case, in isolation, is predominantly a Second Amendment case,” he said.

“But when you combine hemp-derived THC, Hemani, and Schedule III, it’s certainly hard to argue that we aren’t moving toward a more reasonable federal policy on cannabis.”

Rather than changing capital markets overnight, the decision contributes to a broader trend of federal normalization that investors have been watching closely.

The Biggest Legal Question Still Hasn’t Been Answered

Despite the significance of the ruling, the Court deliberately left one major issue unresolved.

“What remains unanswered,” Russell explained, “is where the line is when someone becomes ‘too dangerous’ to own a firearm.”

Following United States v. Rahimi, domestic violence offenders can still be prohibited from firearm ownership.

Following Hemani, casual cannabis users cannot automatically be treated the same way.

The difficult legal question lies somewhere in between.

“After United States v. Rahimi, we know that domestic violence offenders are too dangerous, and after Hemani, we know that casual drug users are not,” Russell said. “However, that’s a large middle ground of the unknown.”

The Bottom Line

For cannabis operators, Hemani is unlikely to change business overnight.

Dispensaries will not suddenly receive new regulatory authority, banking access will not automatically improve, and Schedule III remains subject to an entirely separate federal process.

But Russell argues the ruling matters because it reflects something larger than firearms.

Each incremental legal decision—from hemp-derived THC to medical rescheduling and now Hemani—moves federal policy another step toward recognizing cannabis consumers as ordinary adults rather than inherently dangerous individuals.

For an industry built on legitimacy, that gradual normalization may ultimately prove just as important as any single regulatory reform.